Because of the growth inhibition and associated apoptotic effects of TL in a wide variety of epithelial and hematological cancer cell lines [5–11], including NSCLC cells [4, 12], we investigated the potential changes in CAV-1 mRNA/protein expression following TL treatment in A549 and NCI-H460 lung cancer cells. The gene discussed is CAV1; the disease is lung carcinoma.